Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector




















Sort by: Date|Relevance

NantKwest Shares Jump More than 50% Following JP Morgan Healthcare Conference Presentation

Shares of NantKwest Inc. spiked as much as 85% higher in mid-morning trading setting a new 52-week high price after the company reported a series of positive results at the 38th J.P. Morgan Healthcare Conference in San Francisco. The firm reported that complete responses were ...

Ovid Therapeutics Posts Positive Data from Phase 2 Seizure Reduction Trial

Ovid Therapeutics' shares are trading 25% higher today after the company reported positive initial data from its ENDYMION soticlestat phase 2 trial for patients with developmental and epileptic encephalopathies. Shares of Ovid Therapeutics Inc. (OVID:NASDAQ) are tra...

Apache and Total Form $5 Billion Joint Venture to Drill off Suriname Coast

Shares of Apache Corp. traded 16% higher today after the company reported that it has formed a joint venture with Total SA of France to explore and develop Block 58 offshore Suriname. Late yesterday evening, oil and gas exploration and production company Apache Corp....

AIM ImmunoTech Shares Soar as Japan's NIID Tests Ampligen® as Potential Coronavirus Treatment

Shares of AIM ImmunoTech traded more than 150% higher after the company reported that Japan's National Institute of Infectious Diseases will test its Ampligen® drug as a potential treatment for the coronavirus. Immuno-pharmaceutical company AIM Imm...

Full Circle Lithium to go public

Full Circle Lithium has strategically positioned itself with a team who has 70-years of experience. Armed with a diversified portfolio of feedstock, Full Circle Lithium has up to 2,000 tonnes of capacity which it plans on filling before expanding. The company also has pro...

Unveiling Silvercorp's golden potential at the Ying Mining District

By Dr. Ryan D. Long, Mining and Metals Research Corp . Silvercorp Metals Inc. ( TSX:SVM ) ( NYSE:SVM ) invited a group of analysts to an informational call on the geology of the Ying Mining District, China, where the company operates a number of mines and recently ...

FDA Approval of Biopharma's Pain Drug Expected This Year

The reasons a green light is anticipated and how it relates to the closing of Avenue Therapeutics' pending acquisition are discussed in an H.C. Wainwright & Co. report. In a Feb. 13 research note, H.C. Wainwright & Co. analyst Ed Arce reported that the U.S. ...

From Distilling to Fulfilling

Christina Lake Cannabis Produces First Ultra-High Potency Distillates and Commences Marketing to CPG Industry Christina Lake Cannabis Corp. ( CSE:CLC ) (FRANKFURT: CLB) is beginning to produce ultra-high potency cannabis distillate oils from its 32,500 kg / 71,650 lb har...

Revolutionizing immunotherapies with groundbreaking DPX platform

The following is a transcription of the above video, and The Market Online has edited it for clarity . BioVaxys Technology Corp (CSE:BIOV) is a Canadian-based clinical stage biopharmaceutical company focused on improving patient lives with novel immunotherapies. CE...

Understanding Trading Risks Is Crucial For Your Success

This article will most likely open your eyes and see a side of trading you usually don't think about or possibly don't understand, even though it is critical for your long term success as a trader and investor. Not many people talk about trading risks and for a good reason...
1 2 3 4 5 6 7 8 9 10 ...